WARCEFWarfarin Versus Aspirin for Reduced Cardiac Ejection Fraction
References in periodicals archive ?
Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators.
Data Source: The WARCEF trial, which randomized 2,305 patients with a left ventricular ejection fraction of 35% or less and normal sinus rhythm at 176 centers in 11 countries.
Disclosures: WARCEF was sponsored by the National Institute of Neurological Disorders and Stroke.